Use of the TD50 99 % CI for single dose rodent carcinogenicity studies.

Toxicol Lett

Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, UK.

Published: December 2023

The Tumorigenic dose 50 (TD) is a widely used measure of carcinogenic potency representing the dosage at which 50 % of animals exposed to a compound will develop tumours. The popularity of the TD is in part due to the large amount of publicly available data. TDs were calculated for a large number of compounds in the Carcinogenic Potency Database, which has since been extended in the freely available Lhasa Carcinogenicity database, containing TDs from over 7500 studies and 1700 compounds. However, due to the age of these studies many are of low quality, often comprising only a single test dosage, therefore raising questions about the applicability of such TDfor toxicological risk assessment. We investigate whether the lower 99 % confidence interval is sufficient to produce conservative TD estimates for these studies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxlet.2023.10.015DOI Listing

Publication Analysis

Top Keywords

carcinogenic potency
8
td50 single
4
single dose
4
dose rodent
4
rodent carcinogenicity
4
studies
4
carcinogenicity studies
4
studies tumorigenic
4
tumorigenic dose
4
dose measure
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!